Gateway Investment Advisers LLC Sells 2,783 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gateway Investment Advisers LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 109,554 shares of the medical equipment provider’s stock after selling 2,783 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Intuitive Surgical were worth $57,183,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical during the third quarter worth about $558,807,000. International Assets Investment Management LLC grew its position in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the period. FMR LLC increased its stake in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB raised its holdings in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, State Street Corp lifted its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent research reports. Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Citigroup lifted their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, Truist Financial upped their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Stock Down 0.9 %

NASDAQ:ISRG traded down $5.37 during trading hours on Thursday, hitting $574.74. 182,925 shares of the company’s stock traded hands, compared to its average volume of 1,457,040. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $585.50. The business’s fifty day simple moving average is $537.05 and its two-hundred day simple moving average is $496.50. The firm has a market cap of $204.71 billion, a P/E ratio of 92.40, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 26.54 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. This represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock valued at $25,012,927 over the last three months. 0.80% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.